Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             43 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case of bilateral reversible thalamic lesions Miyakawa, E.
1997
7 4 p. 470-473
artikel
2 Amyloidosis of the seminal vesicles simulating tumor invasion of prostatic carcinoma on endorectal MR images Jager, G. J.
1997
7 4 p. 552-554
artikel
3 Antrochoanal autopolypectomy: CT findings Pruna, X.
1997
7 4 p. 571-572
artikel
4 Application of a stable cell culture assay for the functional assessment of novel MR contrast agents Reimer, P.
1997
7 4 p. 527-531
artikel
5 Bone marrow relaxation times in Gaucher disease before and after enzyme replacement therapy Magnaldi, S.
1997
7 4 p. 486-491
artikel
6 Cardiovascular and electrocardiographic effects of iopentol in left ventricular angiographyComparison of the low-osmolar, non-ionic iopentol (Imagopaque® 350) and the hyper-osmolar, ionic metrizoate meglumine-Na-Ca (Isopaque® Coronar 370) in patients with coronary heart disease Vik-Mo, H.
1997
7 4 p. S156-S161
artikel
7 Cervical diastematomyelia and syringohydromyelia in a myelomeningocele patient Jaeger, H. J.
1997
7 4 p. 477-479
artikel
8 Choledocholithiasis after Billroth II surgery: MR cholangiographic diagnosis Holzknecht, N.
1997
7 4 p. 520-523
artikel
9 Contrast agents for MR imaging of the liver: a clinical overview Mahfouz, A.-E.
1997
7 4 p. 507-513
artikel
10 Contrast media in MR arthrography of the glenohumeral joint: intra-articular gadopentetate vs saline: preliminary results Zanetti, M.
1997
7 4 p. 498-502
artikel
11 CT and MR imaging of craniopharyngioma Tsuda, M.
1997
7 4 p. 464-469
artikel
12 CT and MRI of amyloidoma of the CNS Caerts, B.
1997
7 4 p. 474-476
artikel
13 Delayed CT of the kidneys after iopentol (Imagopaque® 350) injection in patients with normal renal functionAn assessment of the gradual decrease in opacification over 32 h after injection Rickards, D.
1997
7 4 p. S149-S151
artikel
14 Detection of radiographic findings in lung fibrosis using storage phosphor plates Müller, R.-D.
1997
7 4 p. 576-582
artikel
15 Diagnostic value of MR imaging in comparison to CT in the detection and differential diagnosis of renal masses: ROC analysis Kreft, B. P.
1997
7 4 p. 542-547
artikel
16 Eccrine porocarcinoma with intracerebral extension Sigal, R.
1997
7 4 p. 573-575
artikel
17 Evaluation of iopentol (Imagopaque® 350) in CT enhancementA multi-centre monitoring trial assessing adverse events and diagnostic information – results from 1,823 patients in France Oxaal, M.
1997
7 4 p. S109-S114
artikel
18 Imaging findings in renal hydatid disease Vargas-Serrano, B.
1997
7 4 p. 548-551
artikel
19 Imaging findings of sternal abnormalities Franquet, T.
1997
7 4 p. 492-497
artikel
20 Iopentol (Imagopaque® 300 and 350) compared with iohexol (Omnipaque® 300 and 350) in cerebral and aortic arch angiographyA clinical trial assessing adverse events and diagnostic information Ericsson, K.
1997
7 4 p. S152-S155
artikel
21 Iopentol (Imagopaque® 350) compared with diatrizoate (Urografin® 370) in cerebral CTA clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements) Valentine, A.
1997
7 4 p. S145-S148
artikel
22 Iopentol (Imagopaque® 250) compared with diatrizoate (Urografin® 219) in endoscopic retrograde cholangio-pancreatography (ERCP)A clinical trial assessing safety (adverse events and S-pancreatic iso-amylase) and diagnostic information (VAS) Kruse, A.
1997
7 4 p. S131-S134
artikel
23 Iopentol (Imagopaque® 300) compared with iohexol (Omnipaque® 300) and diatrizoate (Urografin® 292) in pediatric urographyA clinical trial assessing adverse events and diagnostic information Lanning, P.
1997
7 4 p. S120-S122
artikel
24 Iopentol (Imagopaque® 350) compared with iohexol (Omnipaque® 350) in pediatric cardioangiographyA clinical trial assessing adverse events, ECG, blood pressure and diagnostic information Kunnen, M.
1997
7 4 p. S123-S126
artikel
25 Iopentol (Imagopaque® 300) compared with iopromide (Ultravist® 300) in abdominal CTA multi-centre monitoring trial assessing adverse events and diagnostic information – results from 518 patients in Spain Encina, J. L.
1997
7 4 p. S115-S119
artikel
26 Iopentol (Imagopaque® 300) compared with iopromide (Ultravist® 300) in pediatric angiocardiographyA clinical trial assessing adverse events, ECG and diagnostic information Piéchaud, J. F.
1997
7 4 p. S127-S130
artikel
27 Iopentol (Imagopaque® 300) compared with ioxaglate (Hexabrix® 320) in knee arthrographyA clinical trial assessing immediate and late adverse events and diagnostic information Railhac, J. J.
1997
7 4 p. S135-S139
artikel
28 Iopentol (Imagopaque®) in vascular proceduresA multi-centre monitoring trial assessing adverse events and diagnostic information – results from 3,587 patients in Germany Muth, C.-P.
1997
7 4 p. S104-S108
artikel
29 Is it possible to choose the safest contrast media through the results of clinical studies? Stacul, F.
1997
7 4 p. 532-533
artikel
30 Kissing osteochondromata leading to synostoses Bessler, W.
1997
7 4 p. 480-485
artikel
31 Late presentation of solitary contralateral adrenal metastasis of renal cell carcinoma Mesurolle, B.
1997
7 4 p. 557-558
artikel
32 Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience Lencioni, R.
1997
7 4 p. 514-519
artikel
33 MR anatomy and small lesions of the eye: improved delineation with a special surface coil Hosten, N.
1997
7 4 p. 459-463
artikel
34 MRI, CT, and TRUS imaging of seminal vesicle metastasis Larsson, P.
1997
7 4 p. 555-556
artikel
35 MRI of the nasal cavity, the paranasal sinuses and orbits in Wegener's granulomatosis Muhle, C.
1997
7 4 p. 566-570
artikel
36 Oral administration of iopentol (Imagopaque® 300 mg I/ml) compared with amidotrizoate (Peritrast® 300 mg I/ml), both diluted to 2 % (v/v), in imaging of the gastrointestinal tract in abdominal contrast enhanced CTA clinical trial assessing patient tolerance, distribution of contrast medium and Hounsfield unit measurements Friedrich, J. M.
1997
7 4 p. S140-S144
artikel
37 Pneumomediastinum and pneumopericardium due to malignant subcarinal lymphadenopathy: CT demonstration Oberholzer, K.
1997
7 4 p. 583-585
artikel
38 Posttraumatic intestinal stenosis: radiographic and sonographic appearance Loberant, N.
1997
7 4 p. 524-526
artikel
39 Primary solitary amyloidoma of the lung: findings on CT and MRI Matsumoto, K.
1997
7 4 p. 586-588
artikel
40 Quality assurance programme applied to mobile C-arm fluoroscopy systems Tuohy, B.
1997
7 4 p. 534-541
artikel
41 Quiz case of the month Tomczak, R.
1997
7 4 p. 589-590
artikel
42 Solitary plasmacytomas of the occipital bone: a report of two cases Okamoto, K.
1997
7 4 p. 503-506
artikel
43 Ultrasound of the hollow gastrointestinal tract in children King, S. J.
1997
7 4 p. 559-565
artikel
                             43 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland